Related Research Articles
An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.
Burkitt lymphoma is a cancer of the lymphatic system, particularly B lymphocytes found in the germinal center. It is named after Denis Parsons Burkitt, the Irish surgeon who first described the disease in 1958 while working in equatorial Africa. The overall cure rate for Burkitt lymphoma in developed countries is about 90%, but worse in low-income countries. Burkitt lymphoma is uncommon in adults, in whom it has a worse prognosis.
Myc is a family of regulator genes and proto-oncogenes that code for transcription factors. The Myc family consists of three related human genes: c-myc (MYC), l-myc (MYCL), and n-myc (MYCN). c-myc was the first gene to be discovered in this family, due to homology with the viral gene v-myc.
N-myc proto-oncogene protein also known as N-Myc or basic helix-loop-helix protein 37 (bHLHe37), is a protein that in humans is encoded by the MYCN gene.
Suzanne Cory is an Australian molecular biologist. She has worked on the genetics of the immune system and cancer and has lobbied her country to invest in science. She is married to fellow scientist Jerry Adams, also a WEHI scientist, whom she met while studying for her PhD at the University of Cambridge, England.
The miR-17 microRNA precursor family are a group of related small non-coding RNA genes called microRNAs that regulate gene expression. The microRNA precursor miR-17 family, includes miR-20a/b, miR-93, and miR-106a/b. With the exception of miR-93, these microRNAs are produced from several microRNA gene clusters, which apparently arose from a series of ancient evolutionary genetic duplication events, and also include members of the miR-19, and miR-25 families. These clusters are transcribed as long non-coding RNA transcripts that are processed to form ~70 nucleotide microRNA precursors, that are subsequently processed by the Dicer enzyme to give a ~22 nucleotide products. The mature microRNA products are thought to regulate expression levels of other genes through complementarity to the 3' UTR of specific target messenger RNA.
snoRNA U50 is a non-coding RNA (ncRNA) molecule which functions in the modification of other small nuclear RNAs (snRNAs). This type of modifying RNA is usually in the nucleolus of the eukaryotic cell which is a major site of snRNA biogenesis. It is known as a small nucleolar RNA (snoRNA) and also often referred to as a guide RNA.
Cyclin D1 is a protein that in humans is encoded by the CCND1 gene.
MYC proto-oncogene, bHLH transcription factor is a protein that in humans is encoded by the MYC gene which is a member of the myc family of transcription factors. The protein contains basic helix-loop-helix (bHLH) structural motif.
Proto-oncogene serine/threonine-protein kinase Pim-1 is an enzyme that in humans is encoded by the PIM1 gene.
Protein SSX2 is a protein that in humans is encoded by the SSX2 gene.
L-myc-1 proto-oncogene protein is a protein that in humans is encoded by the MYCL1 gene.
Bromodomain-containing protein 4 is a protein that in humans is encoded by the BRD4 gene.
Protein SSX1 is a protein that in humans is encoded by the SSX1 gene.
Protein lyl-1 is a protein that in humans is encoded by the LYL1 gene.
Joshua T. Mendell, M.D., Ph.D., is a professor of molecular biology at the University of Texas Southwestern Medical Center, where he is a Howard Hughes Medical Institute Investigator. Before moving to UT Southwestern, Mendell was a Howard Hughes Medical Institute early career scientist at Johns Hopkins School of Medicine. His molecular biology research examines microRNA (miRNA) regulation and function, with particular emphasis on miRNAs and cancer.
Genome instability refers to a high frequency of mutations within the genome of a cellular lineage. These mutations can include changes in nucleic acid sequences, chromosomal rearrangements or aneuploidy. Genome instability does occur in bacteria. In multicellular organisms genome instability is central to carcinogenesis, and in humans it is also a factor in some neurodegenerative diseases such as amyotrophic lateral sclerosis or the neuromuscular disease myotonic dystrophy.
Raji is the first continuous human cell line of hematopoietic origin. The Raji cell line is widely used as a transfection host.
EWS/FLI1 is an oncogenic protein that is pathognomonic for Ewing sarcoma. It is found in approximately 90% of all Ewing sarcoma tumors with the remaining 10% of fusions substituting one fusion partner with a closely related family member.
References
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Entrez Gene: PVT1 Pvt1 oncogene homolog, MYC activator (mouse)".
- ↑ Cory S, Graham M, Webb E, Corcoran L, Adams JM (March 1985). "Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene". The EMBO Journal. 4 (3): 675–681. doi:10.1002/j.1460-2075.1985.tb03682.x. PMC 554241 . PMID 3924592.
- ↑ Graham M, Adams JM (November 1986). "Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus". The EMBO Journal. 5 (11): 2845–2851. doi:10.1002/j.1460-2075.1986.tb04578.x. PMC 1167233 . PMID 3024964.
- ↑ Villeneuve L, Rassart E, Jolicoeur P, Graham M, Adams JM (May 1986). "Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas". Molecular and Cellular Biology. 6 (5): 1834–1837. doi:10.1128/MCB.6.5.1834. PMC 367714 . PMID 3785181.
- ↑ Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, Feo S (November 2007). "The PVT-1 oncogene is a MYC protein target that is overexpressed in transformed cells". Journal of Cellular Physiology. 213 (2): 511–518. doi: 10.1002/jcp.21133 . PMID 17503467.
- 1 2 Cui M, You L, Ren X, Zhao W, Liao Q, Zhao Y (February 2016). "Long non-coding RNA PVT1 and cancer". Biochemical and Biophysical Research Communications. 471 (1): 10–14. doi:10.1016/j.bbrc.2015.12.101. PMID 26850852.
- ↑ Liu HT, Fang L, Cheng YX, Sun Q (December 2016). "LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a". Cancer Medicine. 5 (12): 3512–3519. doi:10.1002/cam4.900. PMC 5224852 . PMID 27794184.
- ↑ Ogunwobi OO, Kumar A (August 2019). "Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus". Frontiers in Oncology. 9 (1): 834. doi: 10.3389/fonc.2019.00834 . PMC 6718704 . PMID 31508377.